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from the Genetic Analysis Workshop 17 data
Aldi T Kraja*, Jacek Czajkowski, Mary F Feitosa, Ingrid B Borecki, Michael A Province
From Genetic Analysis Workshop 17
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Abstract
We present an evaluation of discovery power for two association tests that work well with common alleles but are
applied to the Genetic Analysis Workshop 17 simulations with rare causative single-nucleotide polymorphisms
(SNPs) (minor allele frequency [MAF] < 1%). The methods used were genome-wide single-SNP association tests
based on a linear mixed-effects model for discovery and applied to the familial sample and sliding windows
haplotype association tests for replication, implemented within causative genes in the unrelated individuals sample.
Both methods are evaluated with respect to the simulated trait Q2. The linear mixed-effects model and haplotype
association tests failed to detect the rare alleles of the simulated associations. In contrast, the linear mixed-effects
model and haplotype association tests detected effects for the most important simulated SNPs with MAF > 1%.
We conclude that these findings reflect inadequate statistical power (the result of small simulated samples) for the
complex genetic model that underlies these data.
Background
Based on evolutionary history, it is expected that human
genomes will be arranged into local regions with high
haplotype similarity intermingled with local regions with
haplotype diversity. In the diverse haplotype regions,
rare alleles may play an important role in creating the
foundation for individual subjects’ susceptibility or resistance to a particular disease. It is a common practice in
genetic research to identify causative disease regions in
the framework of association using single single-nucleotide polymorphism (SNP) tests or by grouping neighboring regions under identifiable haplotypes and to test
their association with disease and quantitative traits.
Genetic Analysis Workshop 17 (GAW17) provides 200
replicates of simulated data of a family-based cohort
with eight large families and 200 replicates of simulated
data for unrelated individuals. This simulated problem is
challenging, because both sets of data are relatively
* Correspondence: aldi@wustl.edu
Division of Statistical Genomics, Center for Genome Sciences & Systems
Biology, Washington University School of Medicine, 4444 Forest Park
Boulevard, St. Louis, MO 63110, USA

small (n = 697). We investigate the two problems independently to determine whether the family-based association tests have power to detect rare allele effects and
whether rare allele effects in the simulated genes can
also be detected by haplotype analysis of the unrelated
individuals sample.

Methods
The GAW17 data represent 200 replicates of simulated
phenotypes for a sample of 697 subjects organized in 8
large families (referred in this article as the familial sample) and 200 replicates of simulated phenotypes for a
separate sample of data of 697 unrelated individuals
(referred to here as the unrelated sample). Genotypes
from the 1000 Genomes Project were used as the genotype sample for the unrelated sample. The GAW17
simulation authors [1] used the family data set, by
means of the program CHRSIM [2], to drop the phased
founder genotypes throughout the rest of the pedigree
by considering a single obligate crossover event occurring on each chromosome. The same two genotype sets
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were used for all 200 phenotypic simulation replicates
for the familial or unrelated sample.
We analyzed the unrelated sample genotypes for linkage disequilibrium using HaploView software (version
4.2), with the purpose of identifying tag SNPs [3]. The
options we used in a batch mode run of HaploView for
identifying tag SNPs were –pairwiseTagging and –
tagrsqcutoff 0.8. We used the number of discovered tag
SNPs as a denominator for extrapolating the Bonferroni
genome-wide significance threshold for a single-SNP
association test (see Results section).
After setting a genome-wide significance threshold, we
applied a linear mixed effects (LME) model to the familial sample. The LME statistical analyses are based on
linear estimates of additive genetic effects of single
SNPs. The LME model is:
E(Y g , cov) = a + b 1g + b 2 cov ,

(1)

where b1g measures the change in Y as a result of the
additive change in the genotype gÎ(−1, 0, +1) where −1
is the code for the homozygote genotype for the minor
allele, 0 is the code for the heterozygote, and +1 is the
code for the homozygote for the major allele. We implemented association tests using a statistical mixed model
on the familial sample via the mixed procedure (PROC
MIXED) of SAS (version 9.2, Linux OS). The “repeated”
statement was used with sub=pedid, which defines the
structure of the R matrix, and the covariance structure
was selected as UN. We tested all 24,487 SNPs included
in the simulation, although we had prior knowledge of
the GAW17 simulation answers. With such prior knowledge we focused on trait Q2.
Q2 was simulated as a quantitative trait, influenced
primarily by 72 SNPs in 13 genes, with 1–15 functional
variants per gene and with minor allele frequencies
(MAFs) ranging from 0.07% to 17.07%. The residual

Figure 1 Genome-wide linear mixed effects additive model association test results of 200 replications of family-based cohort data on
Q2 residuals. None of the SNPs’ −log10p mean values passed the 5.4 genome-wide threshold. Sens. = sensitivity. Red triangles mark
chromosomes that were simulated with Q2 causative SNPs (72 of them in 13 genes).
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heritability of Q2 was simulated to be 29%. Most of the
genes affecting the Q2 trait were selected to be related
to cardiovascular disease risk and inflammation, and
they are located on chromosomes 2, 3, 6–12, and 17.
Before the LME association tests, we performed a stepwise regression for Q2 within Sex to remove the effects
of Age and Age2. As a result, we produced a Q2 residual, which we then used as the dependent variable Y in
our analyses. In the statistical analyses, the variable Sex
was included as a covariate (b2cov).
We applied haplotype association tests only in the
unrelated individuals sample and specifically within causative simulated genes. We viewed the haplotype analysis as a replication analysis by completing it in the
unrelated sample for only trait Q2 simulated causative
genes. This was justified by the preceding gain of information from the LME analysis and from the knowledge
we had of the simulated model for Q2. We implemented
the haplotype analyses using Haplo.Stats, version 1.4.4
[4]. The haplotypes studied were created by sliding windows of two and windows of three adjacent SNPs. This
program was run in a batch mode in R software, version
2.10.0, for Linux OS. The Haplo.Stats package includes
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an EM algorithm to estimate haplotype frequencies for
unrelated subjects. In the haplo.score function (within
this package), Schaid et al. [4] implemented the score
statistics Ub and Vb, where:
N

Ub =

Yi − Y i

∑ a(∅)

X gi

(2)

i =1

is a measure of covariation of residuals with the
recoded genotypes and:
−1
V b = V bb − V ba Vaa
Vab

(3)

is the variance. To test the association of the trait and
marker haplotypes, Schaid et al. [4] also provided a global score statistic S,
S = U ′b V b−1U b ,

(4)

with a chi-square distribution and degrees of freedom
equal to the rank of Vb.
Finally, we use two definitions to summarize the LME
results: sensitivity and specificity. Sensitivity is the

Figure 2 Sensitivity and specificity of SNPs discovery by using the linear mixed-effects additive model on gene bases for the Q2 simulated trait
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proportion of true-positive causative SNPs that have a
significant test result in 200 replications; and specificity
is the proportion of true-negative SNPs that have a
negative test result in 200 replications. Both sensitivity
and specificity are expressed as percentages.

Results
The HaploView linkage disequilibrium analysis on all
24,487 markers in the unrelated sample identified
11,626 tag SNPs. Therefore our Bonferroni genomewide significance (a = 0.05) threshold p-value for independent tests was 4.3 × 10−6 (−log10p = 5.4). Figure 1
shows the results of the average −log10p single-SNP genome-wide significance of 200 replications in families
produced by fitting an additive genetic model on Q2
residuals. The average of −log10 p for 200 replications
was for all simulated SNPs under the 5.4 (−log 10 p)
threshold. In particular, a group of SNPs simulated in
genes VNN1 (C6S5380, MAF = 17.9%) on chromosome
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6 and LPL (C8S442, MAF = 4.2%) showed to some
extent significant results.
Figure 2 shows the sensitivity per simulated gene by
selecting the most significant representative SNP. For
example, sensitivity was 37.5% for LPL (marker C8S442)
and 34.5% for VNN1 (marker C6S5380). The specificity
for noncausative genes of these tests was very high,
>99% (Figure 2).
We performed association tests for all causative genes,
with sliding windows of haplotypes taken two or three
markers at a time, in the unrelated sample. Both types of
sliding windows incorporated the detectable effects of the
simulated data. For example, haplotype C8S441-C8S442C8S443 with a frequency of 1.6% in the gene LPL was
associated significantly with Q2 (Figure 3). Another haplotype that included marker C8S442 (C8S442-C8S443C8S444) and had the same frequency of 1.6% also
showed significant association with Q2. In genes VNN3
and VNN1 a few haplotypes (with two-marker windows)

Figure 3 Three-marker sliding windows haplotypes for the LPL gene. Haplotypes containing the SNP C8S442, although close to rare
haplotypes (frequency 1.6), showed distinct association with Q2 trait.
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showed significant association with Q2, for example, haplotype C6S5448-C6S5449 with a frequency of 1% and
haplotype C6S5379-C6S5380 with a frequency of 17.1%
(Figure 4). When using the genome-wide significance
threshold of −log10p of 5.4, sensitivity on genes VNN3
and VNN1 of the most significant haplotype (C6S5379C6S5380) was 11.5%, and for LPL (haplotype C8S441C8S442-C8443) the sensitivity was 2%. Otherwise, if we
considered the haplotype analysis in the unrelated sample
as a replication of the preliminary discovery in the familial sample and set the significance threshold to a value
corresponding to the number of haplotype windows tests
per gene, then the corresponding sensitivity became
22.9% for LPL and 64.5% for VNN3 and VNN1. Other
haplotypes from other rare allele SNP simulated regions
did not confirm significant results.

Discussion
Detecting association of very rare alleles (MAF < 1%)
with disease or quantitative traits in familial data of
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small sample size is challenging. One would have
guessed that in the GAW17 data set, because of its
simulation as a transmission of selected alleles from the
unrelated sample into the familial sample, one or more
rare alleles would have been transmitted as common
alleles in the familial sample. In the simulated data such
conversion from rare alleles into common ones with the
existing small sample sizes (from unrelated founders
into familial data) was not present. Therefore in both
sets of genotypic data, simulations were performed
mostly on the very rare alleles in 96% of the 72 selected
SNPs for Q2. The average −log 10 p-value of genomewide association tests on the simulated data was less
than the significance threshold. This illustrates the
necessity of finding other methods that manage association tests for rare alleles.
With the massive data dumps coming from new
sequencing technologies, rare alleles will be captured
more often in the data and will be the aim of many
studies. Moreover, it is believed that rare alleles are

Figure 4 Two-marker sliding windows haplotypes for genes VNN3 and VNN1. Haplotypes containing C6S5380 and C6S5449 show distinct
association with Q2.
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the gold dust that confer the rest of disease heritability. It is possible that, in contrast to this simulation,
sample sizes in real data will become larger as the
costs of sequencing decrease. But in the existing case
we needed to find ways to increase our statistical
power to identify the rare causative variants in association with disease or quantitative traits. Therefore we
used a two-step analysis design: the LME model for
discovering genome-wide causative SNPs or genes in
the familial sample and haplotype association tests for
replicating primary findings, but now in the unrelated
sample.
The haplotype association test has more power to
identify the SNPs’ effect on disease and quantitative
traits. The haplotype association tests produced significant results for several common haplotypes, including
those with a frequency close to 1%. However, this
method also failed to identify any other significant
haplotypes in association with Q2 from the very rare
simulated SNPs (MAF < 1%). Based on our results for
200 replications, we conclude that failing to detect the
very rare causative SNPs was not a failure of the
methods but more a reflection of the low statistical
power available with the small sample size of the
simulated data.

Conclusions
The genotypic data analyzed from the 1000 Genomes
Project (sampled real data) based on unrelated individuals show that for the selected gene regions there is
an important saving of about 53% when tag SNPs are
used rather than the full sequence. The other dimension of the data, the sample size of 697 individuals
used in this simulation, was small, and thus although
sequence data were available, the power of association
analysis was low. Therefore the additive single-SNP
association tests based on LME models in small samples of data failed to detect the simulated causative
very rare polymorphisms. The association tests based
on haplotype analyses improved the p-value strength
by replicating discovered causative polymorphisms, but
they still failed with very rare alleles, reflecting the
inadequate statistical power of small sample sizes in
the simulated data.
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